Pharmacological Agents Affecting Emesis

@article{Mitchelson2012PharmacologicalAA,
  title={Pharmacological Agents Affecting Emesis},
  author={Frederick J Mitchelson},
  journal={Drugs},
  year={2012},
  volume={43},
  pages={295-315}
}
SummaryThe availability of radiolabelled ligands selective for various putative neurotransmitter receptor sites and the development of quantitative autoradiography has led to a greater understanding of the neuronal pathway and receptor subtypes involved in the vomiting reflex induced by various mechanisms both within the central nervous system and the periphery. Receptors for acetylcholine, dopamine, histamine and serotonin have been detected in a number of brain regions associated with the… 

Figures and Tables from this paper

Intravenous Administration of Apomorphine Does NOT Induce Long QT Syndrome: Experimental Evidence from In Vivo Canine Models
TLDR
The results suggest that apomorphine may possess a wide margin of cardiovascular safety contrary to the authors' expectations, which would be in line with previous studies of D1/D2 receptor agonists.
Enhanced tolerability of the 5-hydroxytryptophane challenge test combined with granisetron
TLDR
Addition of granisetron to the combined 5-HTP/CBD challenge suppresses nausea and vomiting without influencing the neuroendocrine response or pharmacokinetics, enhancing its clinical applicability in future psychiatric research and drug development.
Dietary and Pharmacological Management of Severe Catabolic Conditions
  • E. Elamin
  • Medicine, Biology
    The American journal of the medical sciences
  • 2011
TLDR
Information from this review will guide health care providers in limiting weight loss and improve performance status of the cachectic patients through dietary and pharmacological therapy, with the hope that such approach would extend patients survival and improve their quality of life.
Treatment of Nausea and Vomiting in Terminally I11 Cancer Patients
TLDR
The current approach to the palliative care of patients with nausea and vomiting is based on identifying the cause, understanding its patho-physiology and knowing the pharmacology of the drugs available for its amelioration.
Molecular Pharmacology of Phytocannabinoids.
TLDR
This chapter presents an overview of the molecular pharmacology of the seven most thoroughly investigated phytocannabinoids, namely Δ9-tetrahydrocannabinol, Δ9 -tetraydrocannabivarin, cannabinol, Cannabidiol, cannabidivarin), cannabigerol, and cannabichromene.
The Nociceptive Blink Reflex in Migraine: An investigation of endogenous and exogenous modulators on the trigeminal nervous system in migraine sufferers.
TLDR
There was some evidence of interictal sensitisation in migraine sufferers, but this would be better investigated with test stimuli that strongly activate nociceptive afferent fibres in terms of spatial and temporal summation.
...
1
2
3
...

References

SHOWING 1-10 OF 404 REFERENCES
The neuropharmacology of emesis: the role of receptors in neuromodulation of nausea and vomiting.
TLDR
Evidence that links each of these classes of drugs with the distribution of specific neurotransmitter receptor sites on which they may be acting is examined, and possible implications for the identification of the site of action of anticholinergic, antiemetic drugs are discussed.
Pharmacological and anti-emetic properties of ondansetron.
TLDR
Ondansetron has been found to significantly delay the onset of emesis, and reduce the number of retches and vomits in ferrets receiving cisplatin, cyclophosphamide, or radiation, at much lower doses than metoclopramide and without the associated side effects.
Evidence that 5-hydroxytryptamine3 receptors mediate cytotoxic drug and radiation-evoked emesis.
TLDR
A fundamental role for 5-HT3 receptors in the mechanisms mediating severely emetogenic cancer treatment therapies is discussed in terms of a fundamental role to prevent emesis evoked by cytotoxic drugs or by total body irradiation.
Review of Cannabinoids and their Antiemetic Effectiveness
TLDR
Tetrahydrocannabinol, a synthetic cannabinoid, is also an effective antiemetic which is more active than prochlorperazine in preventing chemotherapy-induced emesis, including cisplatin-containing regimens.
BMY-25801, an antiemetic agent free of D2-dopamine receptor antagonist properties.
TLDR
BMY-25801 represents a novel antiemetic acting independently of D2-dopamine receptor mechanisms; however, its exact mode of action remains unknown.
Structure of a cannabinoid receptor and functional expression of the cloned cDNA
TLDR
The cloning and expression of a complementary DNA that encodes a G protein-coupled receptor that is involved in cannabinoid-induced CNS effects (including alterations in mood and cognition) experienced by users of marijuana are suggested.
The role of the abdominal visceral innervation and 5-hydroxytryptamine M-receptors in vomiting induced by the cytotoxic drugs cyclophosphamide and cis-platin in the ferret.
TLDR
BRL 24924, a gastro-kinetic agent with more specific 5-HT M-receptor antagonist properties, was extremely potent in almost totally abolishing retching and vomiting in response to cyclophosphamide, given by either an intravenous or intraperitoneal route.
...
1
2
3
4
5
...